HHS Drug Importation Task Force: FDA Reps Are Crawford, Sachdev
Executive Summary
The HHS Task Force on Drug Importation includes at least three representatives from outside FDA who are likely to be primarily concerned with protecting the pharmaceutical supply chain
You may also be interested in...
Rx Importation Unsustainable Because Of Supply/Demand Imbalance – HDMA
Increased demand for a small amount of Canadian pharmaceuticals would make a legalized importation system unsustainable, drug distributors told the HHS importation task force
PhRMA Braces For Import Fight; Trade Treaties May Help, Sen. Breaux Says
Every U.S. trade agreement should be examined for its potential impact on prescription drug pricing, Sen. John Breaux (D-La.) said during the Pharmaceutical Research & Manufacturers of America's annual meeting in Palm Beach, Fla. April 3
Rx Importation Unsustainable Because Of Supply/Demand Imbalance – HDMA
Increased demand for a small amount of Canadian pharmaceuticals would make a legalized importation system unsustainable, drug distributors told the HHS importation task force